MREO

Mereo BioPharma

53 hedge funds and large institutions have $84.3M invested in Mereo BioPharma in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-5
Holders Change %
-8.62%
% of All Funds
0.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
9
Reduced
21
Closed
11
Calls
$775K
Puts
$28K
Net Calls
+$747K
Net Calls Change
+$693K
Name Holding Trade Value Shares
Change
Shares
Change %
Bank of America
51
Bank of America
North Carolina
$1 -$21.2K -21,182 -100%
O
52
OrbiMed
New York
-$5.48M -7,747,891 Closed
Citigroup
53
Citigroup
New York
-$799K -1,130,650 Closed
FAM
54
Formidable Asset Management
Ohio
-$234K -331,914 Closed
Acadian Asset Management
55
Acadian Asset Management
Massachusetts
-$134K -191,899 Closed
WVP
56
Worth Venture Partners
New Jersey
-$54.1K -76,513 Closed
SEI Investments
57
SEI Investments
Pennsylvania
-$41.5K -58,718 Closed
Bessemer Group
58
Bessemer Group
New Jersey
-$41K -58,000 Closed
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
-$30.5K -43,089 Closed
Creative Planning
60
Creative Planning
Kansas
-$27.1K -38,320 Closed
CL
61
CSS LLC
Illinois
-$7.59K -10,735 Closed
Group One Trading
62
Group One Trading
Illinois
-$5.75K -8,130 Closed